Collegium Pharmaceutical, Inc. (COLL) has been a topic of interest on Reddit forums, particularly among value investors discussing potential buying opportunities. One user noted that Collegium Pharmaceutical is down 33% and described it as a company focused on extended-release opioid analgesics. This has sparked a debate on whether the stock represents a value play or a risky investment. Another user humoro